nucleoside reverse transcriptase inhibitors

DRUG3 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, IRCCS San Raffaele

Conditions

HIV InfectionsHIV Lipodystrophy SyndromeHIV-Associated Lipodystrophy SyndromeHepatitis C

Phase 3

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

IRCCS San RaffaeleHepatitis C, HIV Infections

Start: 2007-02-28End: 2010-12-31Target: 60Updated: 2009-02-06

Phase 4

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

TerminatedNCT00122655

French National Agency for Research on AIDS and Viral HepatitisHIV Infections, HIV Lipodystrophy Syndrome

Start: 2001-01-31End: 2005-06-30Target: 100Updated: 2005-11-15

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

TerminatedNCT00122668

French National Agency for Research on AIDS and Viral HepatitisHIV-Associated Lipodystrophy Syndrome, HIV Infections

Start: 2003-11-30End: 2005-07-31Target: 112Updated: 2005-11-15